ZUITION Trademark

Trademark Overview

On Friday, June 11, 2021, a trademark application was filed for ZUITION with the United States Patent and Trademark Office. The USPTO has given the ZUITION trademark a serial number of 90769022. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, January 23, 2025. This trademark is owned by Pfizer Inc.. The ZUITION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
zuition

General Information

Serial Number90769022
Word MarkZUITION
Filing DateFriday, June 11, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, January 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, January 23, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, March 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 15, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 22, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 3, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 3, 2022SOU EXTENSION 1 FILED
Monday, October 3, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 26, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 26, 2023SOU EXTENSION 2 FILED
Friday, April 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 19, 2023SOU EXTENSION 3 GRANTED
Monday, July 3, 2023ASSIGNED TO EXAMINER
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 19, 2023SOU EXTENSION 3 FILED
Monday, April 1, 2024SOU EXTENSION 4 GRANTED
Monday, April 1, 2024SOU EXTENSION 4 FILED
Monday, April 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU EXTENSION 5 GRANTED
Saturday, October 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 1, 2024SOU EXTENSION 5 FILED
Wednesday, January 22, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, January 23, 2025ABANDONMENT - AFTER PUBLICATION
Thursday, January 23, 2025ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION

Related Keywords

zuition preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone